NORTH AMERICA DRUG DISCOVERY MARKET FORECAST 2019-2027

  • You are here:
  • Home
  • Reports
  • NORTH AMERICA DRUG DISCOVERY MARKET FORECAST 2019-2027

NORTH AMERICA DRUG DISCOVERY MARKET FORECAST 2019-2027

The North American drug discovery market captured a share of XX% in 2018 and is estimated to contribute XX% market share by 2027 in the global market. By the end of the forecast period of 2019-2027, the North America market is expected to rise with 8.63% CAGR and collect a revenue of $XX million.

NORTH AMERICA DRUG DISCOVERY MARKET FORECAST 2019-2027

North America Drug Discovery Market by Technology (High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics and Pharmacogenetics, Combinatorial, Chemistry, Nanotechnology, Spectroscopy, Metabolomics, Other Technologies) by Drug Type (Small Molecule Drug, Biologic Drug) by Service (Drug Metabolism and Pharmacokinetics, (Dmpk) Services, Chemical Services, Biological Services, Other Pharmaceutical Services) by End User (Research Institutes, Pharmaceutical Companies, Contract Research Organizations (Cros), Other End User) by Geography.

Request free sample

The North American drug discovery market captured a share of XX% in 2018 and is estimated to contribute XX% market share by 2027 in the global market. By the end of the forecast period of 2019-2027, the North America market is expected to rise with 8.63% CAGR and collect a revenue of $XX million.

According to the World Health Organization (WHO) report, the prevalence of cardiovascular diseases, coronary heart diseases, hypertension, stroke, and other heart diseases are highest in North America. However, providing cardiology treatment and surgeries in rural and urban regions of North America are still a challenge. As a result, the drug discovery market has a high demand in this region. Further, factors like constant rise in healthcare spending, aging population, the rise of generic drugs, and patent expirations are driving the market growth in the region.

The North America drug discovery market includes economies such as the United States and Canada. The U.S drug discovery market expected to continue its dominance throughout the projected years of 2019-2027 owing to rising healthcare expenditure and increasing research & development activities. Also, the increasing prevalence of chronic diseases showcases the huge market potential for drug discovery in the region.

There are several players in the drug discovery market. One of the notable players in the region is 3M Company, a USA-based manufacturing company. The firm offers technology and products to sectors such as healthcare, industrial, electronics & energy, safety, and others. The company supplies medical tape, orthopedic casting material, dressing, wound closure product, etc. to the medical industry.

 

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

  1. RESEARCH SCOPE
    • STUDY GOALS
    • SCOPE OF THE MARKET STUDY
    • WHO WILL FIND THIS REPORT USEFUL?
    • STUDY AND FORECASTING YEARS
  2. RESEARCH METHODOLOGY
    • SOURCES OF DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • TOP-DOWN APPROACH
    • BOTTOM-UP APPROACH
    • DATA TRIANGULATION
  3. EXECUTIVE SUMMARY
    • MARKET SUMMARY
    • KEY FINDINGS
      • HIGH PREVALENCE RATES OF MAJOR HEALTH DISORDERS
      • IMPLEMENTATION OF DRUG DISCOVERY PROGRAMS
      • BIOINFORMATICS IS THE WIDELY USED DRUG DISCOVERY TECHNOLOGY
      • SMALL MOLECULE DRUG TYPE CONSTITUTES THE HIGHEST MARKET SHARE
      • CONTRACT RESEARCH ORGANIZATIONS (CROS) ARE THE FASTEST-GROWING END USER
  1. MARKET DYNAMICS
    • MARKET SCOPE & DEFINITION
    • MARKET DRIVERS
      • AGING POPULATION
      • BRANDED DRUGS ARE OUTPERFORMING DUE TO HIGH COST COMPARED TO GENERIC DRUGS
      • GROWING HEALTHCARE EXPENDITURE
      • TECHNOLOGICAL ADVANCEMENT
    • MARKET RESTRAINTS
      • DELAY IN PRODUCT LAUNCHES
      • POOR ACCESS TO HEALTHCARE SERVICES IN DEVELOPING MARKETS
      • SHIFT FROM BRANDED TO GENERIC DRUGS
    • MARKET OPPORTUNITIES
      • EXTENSIVE R & D FOR NEW PRODUCT LAUNCHES
      • INCREASING DEMAND FOR SPECIALTY MEDICINES
      • RISING INVESTMENT BY PHARMACEUTICAL COMPANIES IN IMPROVING BIG-DATA ANALYTICAL CAPABILITIES
    • MARKET CHALLENGES
      • COST BARRIER FOR LOCAL PEOPLE IN EMERGING ECONOMIES
      • STRINGENT GOVERNMENT REGULATIONS
  1. MARKET BY TECHNOLOGY
    • HIGH THROUGHPUT SCREENING
    • BIOCHIPS
    • BIOINFORMATICS
    • PHARMACOGENOMICS AND PHARMACOGENETICS
    • COMBINATORIAL CHEMISTRY
    • NANOTECHNOLOGY
    • SPECTROSCOPY
    • METABOLOMICS
    • OTHER TECHNOLOGIES
  2. MARKET BY DRUG TYPE
    • SMALL MOLECULE DRUG
    • BIOLOGIC DRUG
  3. MARKET BY SERVICE
    • DRUG METABOLISM AND PHARMACOKINETICS (DMPK) SERVICES
    • CHEMICAL SERVICES
    • BIOLOGICAL SERVICES
    • OTHER PHARMACEUTICAL SERVICES
  4. MARKET BY END USER
    • RESEARCH INSTITUTES
    • PHARMACEUTICAL COMPANIES
    • CONTRACT RESEARCH ORGANIZATIONS (CROS)
    • OTHER END USER
  5. KEY ANALYTICS
    • PORTER’S FIVE FORCES MODEL
      • THREATS OF NEW ENTRANTS
      • THREAT OF SUBSTITUTE PRODUCTS
      • BARGAINING POWER OF BUYERS
      • BARGAINING POWER OF SUPPLIERS
    • COMPETITIVE RIVALRY
    • VALUE CHAIN ANALYSIS
    • PESTLE ANALYSIS
    • REGULATORY FRAMEWORK
    • OPPORTUNITY MATRIX
  6. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • THE UNITED STATES
      • CANADA
  1. COMPANY PROFILES
    • 3M COMPANY
    • ANTARES PHARMA
    • ASTRAZENECA PLC
    • BAYER AG
    • BECTON, DICKINSON & COMPANY (BD)
    • BOEHRINGER INGELHEIM
    • ELI LILY
    • HOFFMANN-LA ROCHE LTD
    • GLAXOSMITHKLINE LLC
    • JOHNSON AND JOHNSON
    • MERCK & CO. INC.
    • NOVARTIS
    • PFIZER, INC.
    • SANOFI

 

LIST OF TABLES

TABLE 1        NORTH AMERICA DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)

TABLE 2        NORTH AMERICA DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2027 ($ MILLION)

TABLE 3        NORTH AMERICA HIGH THROUGHPUT SCREENING MARKET, 2019-2027 ($ MILLION)

TABLE 4        NORTH AMERICA BIOCHIPS MARKET, 2019-2027 ($ MILLION)

TABLE 5        NORTH AMERICA BIOINFORMATICS MARKET, 2019-2027 ($ MILLION)

TABLE 6        NORTH AMERICA PHARMACOGENOMICS AND PHARMACOGENETICS MARKET, 2019-2027 ($ MILLION)

TABLE 7        NORTH AMERICA COMBINATORIAL CHEMISTRY MARKET, 2019-2027 ($ MILLION)

TABLE 8        NORTH AMERICA NANOTECHNOLOGY MARKET, 2019-2027 ($ MILLION)

TABLE 9        NORTH AMERICA SPECTROSCOPY MARKET, 2019-2027 ($ MILLION)

TABLE 10      NORTH AMERICA METABOLOMICS MARKET, 2019-2027 ($ MILLION)

TABLE 11      NORTH AMERICA OTHER TECHNOLOGIES MARKET, 2019-2027 ($ MILLION)

TABLE 12      NORTH AMERICA DRUG DISCOVERY MARKET, BY DRUG TYPE, 2019-2027 ($ MILLION)

TABLE 13      NORTH AMERICA SMALL MOLECULE DRUG MARKET, 2019-2027 ($ MILLION)

TABLE 14      NORTH AMERICA BIOLOGIC DRUG MARKET, 2019-2027 ($ MILLION)

TABLE 15      NORTH AMERICA DRUG DISCOVERY MARKET, BY SERVICE, 2019-2027 ($ MILLION)

TABLE 16      NORTH AMERICA DRUG METABOLISM AND PHARMACOKINETICS (DMPK) SERVICES MARKET, 2019-2027 ($ MILLION)

TABLE 17      NORTH AMERICA CHEMICAL SERVICES MARKET, 2019-2027 ($ MILLION)

TABLE 18      NORTH AMERICA BIOLOGICAL SERVICES MARKET, 2019-2027 ($ MILLION)

TABLE 19      NORTH AMERICA OTHER PHARMACEUTICAL SERVICES MARKET, 2019-2027 ($ MILLION)

TABLE 20      NORTH AMERICA DRUG DISCOVERY MARKET, BY END USER, 2019-2027 ($ MILLION)

TABLE 21      NORTH AMERICA RESEARCH INSTITUTES MARKET, 2019-2027 ($ MILLION)

TABLE 22      NORTH AMERICA PHARMACEUTICAL COMPANIES MARKET, 2019-2027 ($ MILLION)

TABLE 23      NORTH AMERICA CONTRACT RESEARCH ORGANIZATIONS (CROS) MARKET, 2019-2027 ($ MILLION)

TABLE 24      NORTH AMERICA OTHER END USER MARKET, 2019-2027 ($ MILLION)

TABLE 25      NORTH AMERICA DRUG DISCOVERY MARKET, BY COUNTRY, 2019-2027 ($ MILLION)

 

LIST OF FIGURES

FIGURE 1      NORTH AMERICA DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)

FIGURE 2      NORTH AMERICA DRUG DISCOVERY MARKET SHARE BY TECHNOLOGY 2018 & 2027 (%)

FIGURE 3      NORTH AMERICA DRUG DISCOVERY MARKET, BY HIGH THROUGHPUT SCREENING, 2019-2027 ($ MILLION)

FIGURE 4      NORTH AMERICA DRUG DISCOVERY MARKET, BY BIOCHIPS, 2019-2027 ($ MILLION)

FIGURE 5      NORTH AMERICA DRUG DISCOVERY MARKET, BY BIOINFORMATICS, 2019-2027 ($ MILLION)

FIGURE 6      NORTH AMERICA DRUG DISCOVERY MARKET, BY PHARMACOGENOMICS AND PHARMACOGENETICS, 2019-2027 ($ MILLION)

FIGURE 7      NORTH AMERICA DRUG DISCOVERY MARKET, BY COMBINATORIAL CHEMISTRY 2019-2027 ($ MILLION)

FIGURE 8      NORTH AMERICA DRUG DISCOVERY MARKET, BY NANOTECHNOLOGY, 2019-2027 ($ MILLION)

FIGURE 9      NORTH AMERICA DRUG DISCOVERY MARKET, BY SPECTROSCOPY, 2019-2027 ($ MILLION)

FIGURE 10   NORTH AMERICA DRUG DISCOVERY MARKET, BY METABOLOMICS, 2019-2027 ($ MILLION)

FIGURE 11   NORTH AMERICA DRUG DISCOVERY MARKET, BY OTHER TECHNOLOGIES, 2019-2027 ($ MILLION)

FIGURE 12   NORTH AMERICA DRUG DISCOVERY MARKET SHARE BY DRUG TYPE 2018 & 2027 (%)

FIGURE 13   NORTH AMERICA DRUG DISCOVERY MARKET, BY SMALL MOLECULE DRUG, 2019-2027 ($ MILLION)

FIGURE 14   NORTH AMERICA DRUG DISCOVERY MARKET, BY BIOLOGIC DRUG, 2019-2027 ($ MILLION)

FIGURE 15   NORTH AMERICA DRUG DISCOVERY MARKET SHARE BY SERVICE 2018 & 2027 (%)

FIGURE 16   NORTH AMERICA DRUG DISCOVERY MARKET, BY DRUG METABOLISM AND PHARMACOKINETICS (DMPK) SERVICES, 2019-2027 ($ MILLION)

FIGURE 17   NORTH AMERICA DRUG DISCOVERY MARKET, BY CHEMICAL SERVICES 2019-2027 ($ MILLION)

FIGURE 18   NORTH AMERICA DRUG DISCOVERY MARKET, BY BIOLOGICAL SERVICES, 2019-2027 ($ MILLION)

FIGURE 19   NORTH AMERICA DRUG DISCOVERY MARKET, BY OTHER PHARMACEUTICAL SERVICES, 2019-2027 ($ MILLION)

FIGURE 20   NORTH AMERICA DRUG DISCOVERY MARKET SHARE BY END USER 2018 & 2027 (%)

FIGURE 21   NORTH AMERICA DRUG DISCOVERY MARKET, BY RESEARCH INSTITUTES, 2019-2027 ($ MILLION)

FIGURE 22   NORTH AMERICA DRUG DISCOVERY MARKET, BY PHARMACEUTICAL COMPANIES, 2019-2027 ($ MILLION)

FIGURE 23   NORTH AMERICA DRUG DISCOVERY MARKET, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), 2019-2027 ($ MILLION)

FIGURE 24   NORTH AMERICA DRUG DISCOVERY MARKET, BY OTHER END USER, 2019-2027 ($ MILLION)

FIGURE 25   PORTER’S FIVE FORCE MODEL

FIGURE 26   NORTH AMERICA DRUG DISCOVERY MARKET, REGIONAL OUTLOOK 2018 & 2027 (%)

FIGURE 27   THE UNITED STATES DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)

FIGURE 28   CANADA DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)

 

  1. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • THE UNITED STATES
      • CANADA
  1. MARKET BY TECHNOLOGY
    • HIGH THROUGHPUT SCREENING
    • BIOCHIPS
    • BIOINFORMATICS
    • PHARMACOGENOMICS AND PHARMACOGENETICS
    • COMBINATORIAL CHEMISTRY
    • NANOTECHNOLOGY
    • SPECTROSCOPY
    • METABOLOMICS
    • OTHER TECHNOLOGIES
  2. MARKET BY DRUG TYPE
    • SMALL MOLECULE DRUG
    • BIOLOGIC DRUG
  3. MARKET BY SERVICE
    • DRUG METABOLISM AND PHARMACOKINETICS (DMPK) SERVICES
    • CHEMICAL SERVICES
    • BIOLOGICAL SERVICES
    • OTHER PHARMACEUTICAL SERVICES
  4. MARKET BY END USER
    • RESEARCH INSTITUTES
    • PHARMACEUTICAL COMPANIES
    • CONTRACT RESEARCH ORGANIZATIONS (CROS)
    • OTHER END USER

To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now